HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study. Lehtinen M, Butt J, Gray P, Brenner N, et al. Int J Cancer 2023;153:1313-1315.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lehtinen M, Butt J, Gray P, Brenner N, et al. HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study. Int J Cancer 2023;153:1313-1315.
PMID: 37289012